Pharmaceutical Supply Chain Resilience: Leen Kawas

Leen Kawas highlights the fragility of the pharmaceutical supply chain, heavily reliant on raw materials and manufacturing across the Middle East and Asia, particularly India. Disruptions in key chokepoints like the Strait of Hormuz and rising air cargo costs expose the risk of drug shortages, urging a shift toward building regional manufacturing hubs and embedding resilience into development strategies.

This Wire brief sits within Fusion42's coverage of Biotech.